John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 73,927 shares at $67.86 ($5.2M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Open-market sale of $5.2M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.18 | 8,043 | $540K | 10.4% |
| 2 | $67.18 | 8,043 | $540K | 10.4% |
| 3 | $67.86 | 14,018 | $951K | 18.3% |
| 4 | $67.86 | 14,018 | $951K | 18.3% |
| 5 | $68.78 | 881 | $61K | 1.2% |
| 6 | $68.78 | 881 |
| $61K |
| 1.2% |
| 7 | $75.00 | 28,043 | $2.1M | 40.4% |
| Total | $70.44 avg | 73,927 | $5.2M | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |